Australia markets closed

Apontis Pharma AG (APPH.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
8.66+0.34 (+4.09%)
At close: 05:36PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
3,803
-11,303
2,689
-745.2369
-1,183
-
Depreciation & amortisation
1,845
1,884
1,795
1,746
1,654
-
Change in working capital
-615.4169
-4,349
6,074
-2,494
698.8321
-
Inventory
-603.077
-2,173
2,109
-3,318
1,161
-
Other working capital
2,658
-15,858
7,742
1,773
721.447
-
Other non-cash items
117.9478
1,687
-385.067
4,424
445.8536
-
Net cash provided by operating activities
5,726
-12,596
11,020
3,433
1,451
-
Cash flows from investing activities
Investments in property, plant and equipment
-3,067
-3,263
-3,278
-1,660
-729.5649
-
Acquisitions, net
-
-
-
-
0
-269.6845
Purchases of investments
-221.7184
-57.8567
-53.0007
-121.6349
-48.0034
-
Sales/maturities of investments
55.9
55.9
34.1
0
-
-
Other investing activities
-
-
550
-
-
-
Net cash used for investing activities
-3,143
-2,934
-2,679
-1,773
-777.1679
-
Net change in cash
1,711
-9,529
6,505
21,781
672.2022
-
Cash at beginning of period
30,512
36,345
29,840
8,059
7,387
-
Cash at end of period
32,223
26,816
36,345
29,840
8,059
-
Free cash flow
Operating cash flow
5,726
-12,596
11,020
3,433
1,451
-
Capital expenditure
-3,067
-3,263
-3,278
-1,660
-729.5649
-
Free cash flow
2,658
-15,858
7,742
1,773
721.447
-